Novo Nordisk (Ozempic)

3833.636 - 3860.664 David Rosenthal

And then he goes and convinces the board, both of the operating company Nordisk and the foundation, that this new MC insulin generation, which remember, Novo innovated. that this actually represents a golden opportunity for Nordisk to get back in the game. Because it's going to be a complete reset of all the insulins on the market, whether they're fast-acting or long-lasting insulins.